We are live on
!
Find out more
Parallax Volatility Advisers Portfolio holdings
AUM
$38.6B
1-Year Est. Return
45.89%
This Fund
S&P 500
This Quarter
Est. Return
+3.78%
1 Year Est. Return
+45.89%
3 Year Est. Return
+130.57%
5 Year Est. Return
+159.2%
10 Year Est. Return
+646.93%
AUM
$70.7B
AUM Growth
-$3.62B
(-4.9%)
Cap. Flow
-$5.91B
Cap. Flow
% of AUM
-8.35%
Top 10 Holdings %
Top 10 Hldgs %
59.58%
Holding
4,066
New
804
Increased
529
Reduced
573
Closed
911
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$68.6M |
| 2 |
IBM
IBM
|
+$62.1M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$60M |
| 4 |
AT&T
T
|
+$56.6M |
| 5 |
NVIDIA
NVDA
|
+$54.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$195M |
| 2 |
Amazon
AMZN
|
+$177M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$169M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$144M |
| 5 |
Micron Technology
MU
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 0.87% |
| 2 | Financials | 0.74% |
| 3 | Communication Services | 0.59% |
| 4 | Consumer Discretionary | 0.43% |
| 5 | Healthcare | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
1276
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $494K | ﹤0.01% |
+18,000
| New | +$541K |
|
1277
CALL
Accenture
ACN
$104B
| $491K | ﹤0.01% |
+3,000
| New | +$467K |
|
1278
CALL
Masco
MAS
$15.2B
| $486K | ﹤0.01% |
13,000
| – | – |
|
1279
PUT
BlackBerry
BB
$5.2B
| $483K | ﹤0.01% |
50,000
| – | – |
|
1280
CALL
Intellia Therapeutics
NTLA
$1.58B
| $483K | ﹤0.01% |
+17,700
| New | +$429K |
|
1281
PUT
Insmed
INSM
$21.4B
| $473K | ﹤0.01% |
+20,000
| New | +$515K |
|
1282
CSX Corp
CSX
$94.5B
| $470K | ﹤0.01% |
22,113
+13,752
| +164% | +$283K |
|
1283
Universal Display
OLED
$3.96B
| $470K | ﹤0.01% |
5,468
-58,060
| -91% | -$5.54M |
|
1284
Harley-Davidson
HOG
$2.79B
| $469K | ﹤0.01% |
11,148
-34,550
| -76% | -$1.46M |
|
1285
PUT
Pan American Silver
PAAS
$18.9B
| $469K | ﹤0.01% |
+26,200
| New | +$452K |
|
|
BBBY
1286
Bed Bath & Beyond
BBBY
$530M
| $466K | ﹤0.01% |
+18,428
| New | +$501K |
|
|
CARM
1287
CALL
DELISTED
Carisma Therapeutics
CARM
| $463K | ﹤0.01% |
+11,875
| New | +$523K |
|
|
DVAX
1288
PUT
DELISTED
Dynavax Technologies
DVAX
| $458K | ﹤0.01% |
+30,000
| New | +$519K |
|
|
HIBB
1289
PUT
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $458K | ﹤0.01% |
+20,000
| New | +$521K |
|
1290
CALL
Microchip Technology
MCHP
$43.8B
| $455K | ﹤0.01% |
10,000
-10,600
| -51% | -$491K |
|
1291
Transocean
RIG
$5.78B
| $452K | ﹤0.01% |
33,607
-130,248
| -79% | -$1.6M |
|
|
GBT
1292
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $452K | ﹤0.01% |
+10,000
| New | +$455K |
|
1293
CALL
Lexicon Pharmaceuticals
LXRX
$1.11B
| $450K | ﹤0.01% |
+37,500
| New | +$384K |
|
1294
Pulmatrix
PULM
$6.06M
| $441K | ﹤0.01% |
4,896
+396
| +9% | +$38.5K |
|
1295
Nexstar Media Group
NXST
$5.99B
| $438K | ﹤0.01% |
+5,964
| New | +$403K |
|
1296
CALL
Teradyne
TER
$63.1B
| $434K | ﹤0.01% |
11,400
-30,000
| -72% | -$1.17M |
|
1297
PUT
Cencora
COR
$59.6B
| $426K | ﹤0.01% |
+5,000
| New | +$439K |
|
|
1298
CALL
Insmed
INSM
$21.4B
| $426K | ﹤0.01% |
+18,000
| New | +$463K |
|
1299
PUT
Petrobras
PBR
$121B
| $426K | ﹤0.01% |
42,500
| – | – |
|
1300
PUT
Cleveland-Cliffs
CLF
$7.02B
| $422K | ﹤0.01% |
50,000
| – | – |
|
Similar funds
Parallax Volatility Advisers's Q2 2018 Portfolio in Review
As of Q2 2018, Parallax Volatility Advisers held 4,066 positions worth $70.7B, down 4.9% from $74.4B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Parallax Volatility Advisers withdrew a net $5.91B in Q2 2018, closing 911 positions and reducing 573 holdings. Its most notable exit was Las Vegas Sands, an estimated $49.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 0.87% of assets, down from 0.93% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Parallax Volatility Advisers opened a new position in McKesson worth $24.2M.
- Parallax Volatility Advisers's largest Q2 2018 buy was McKesson: 181,730 shares worth $24.2M.
- Parallax Volatility Advisers added most to Citigroup in Q2 2018, an estimated $68.6M increase.
- Parallax Volatility Advisers's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $195M.
- Parallax Volatility Advisers fully exited Las Vegas Sands in Q2 2018, selling an estimated $49.2M.
- Parallax Volatility Advisers's ten largest holdings make up 60% of its $70.7B portfolio in Q2 2018.
- Parallax Volatility Advisers opened 804 new positions and closed 911 in Q2 2018.
- Parallax Volatility Advisers's portfolio value fell 4.9% quarter-over-quarter to $70.7B.
Based on Parallax Volatility Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.